Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Apimeds Pharmaceuticals US, Inc

APUS•AMEX
Healthcare
Drug Manufacturers - Specialty & Generic
$1.64
$0.02(1.23%)
U.S. Market opens in 16h 0m

Apimeds Pharmaceuticals US, Inc (APUS) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Apimeds Pharmaceuticals US, Inc (AMEX:APUS).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

APUS Technical Analysis Summary

Apimeds Pharmaceuticals US, Inc stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral
Momentum:Neutral to Bearish (RSI: 48.95)
Trend Strength:Weak (ADX: 17.11)
Volatility:High (ATR: 0.18)
Support/Resistance:$1.13 – $1.50 (Bollinger Bands)

Technical conditions suggest Apimeds Pharmaceuticals US, Inc is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 48.95

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 40.30

Neutral
Mid-range signal with no clear trend.

Williams %R: -55.98

Neutral
Balanced market without strong signals.

Rate of Change (ROC): 0.72

Neutral
Price change is minimal.

Takeaway:Apimeds Pharmaceuticals US, Inc shows neutral momentum, with indicators pointing to indecision.

Trend & Volatility

MACD: -0.06

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 17.11

Weak
Weak trend, market trading sideways.

ATR (14): 0.18

Low
Low volatility, stable price action.

CCI (14): 345.61

Bearish Risk
Bearish risk, overbought levels suggest caution.

Takeaway:Apimeds Pharmaceuticals US, Inc shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$1.50
Middle Band (SMA 20)
$1.32
Lower Band
$1.13
Current Position
Above Upper Band

Takeaway:Apimeds Pharmaceuticals US, Inc trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels
Upper Channel
$1.73
Middle Line (EMA 20)
$1.38
Lower Channel
$1.03
Squeeze Status
Squeeze On

Takeaway:Apimeds Pharmaceuticals US, Inc trades above the trend line, showing healthy momentum within the channel.

Volume & Money Flow Analysis
On-Balance Volume1.43M
Money Flow Index81.17Bearish risk, overbought conditions may trigger pullback.
Relative Vigor Index43.24Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:APUS shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Apimeds Pharmaceuticals US, Inc, here are the key trading signals and recommendations:

Bullish Signals

Price trading above middle Bollinger Band → mid-term support intact.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

MFI above 80 → overbought conditions may limit upside.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Apimeds Pharmaceuticals US, Inc shows a Neutral outlook — indicators suggest balanced momentum with no clear directional trend.

Technical Analysis FAQ